- +1-315-215-1633
- sales@thebrainyinsights.com
The global inhalation anaesthetics market is expected to grow from USD 1.78 billion in 2022 to USD 2.76 billion by 2030, at a CAGR of 5.66% from 2022-2030. The Asia Pacific inhalation anaesthetics market is expected to grow the fastest during the forecast period.
With the advancement in medical technology and the expansion of healthcare infrastructure globally, diseases or conditions previously deemed terminal can now be cured or managed in the modern world. New drugs or therapies are bettering the lives of thousands worldwide. The advancement in medicine has enabled medical practitioners to cure illnesses surgically. Better medical devices, equipment and technology have enabled them to improve surgical outcomes. Surgical procedures are invasive. They are long and painful. Anaesthetics numb the body's sensations so that the patient does not feel pain during surgery or biopsies. They are also used in diagnostic or screening tests. The use of anaesthetics to subdue the patient is called anaesthesia in medicine. Anaesthetics are administered, most commonly through IV or inhalation. Some anaesthetics are administered in spray formats or skin patches as well. As the name suggests, inhalation anaesthetics are administered through the respiratory route with a face mask, tracheal tube, or laryngeal mask airway. Nitrous oxide, isoflurane, sevoflurane, halothane and desflurane are some examples of inhalation anaesthetics. Inhalation anaesthetics are safe. They allow flexibility given they can be adjusted quickly according to the requirements. Inhalation anaesthetics are technically more feasible and reduce the overall expenditure cost for the hospital as well as the patient. They are highly effective for long-duration surgeries, which contributes to their growing adoption in the healthcare sector.
Get an overview of this study by requesting a free sample
April 2022 - The first piece of software to semi-automate anaesthetic distribution during surgery has received FDA approval. End-tidal (Et) Control is software that integrates with GE's Aisys CS2 Anesthesia Delivery System and enables anesthesiologists to pre-set the preferred end-tidal oxygen and anaesthetic drug concentrations. The system can adjust to reach and maintain these target levels throughout operation once they are set.
October 2022 – Blue-Zone Technologies, Ltd., a clean-tech pharmaceutical company in Toronto, Canada, raised USD 8 million in institutional funding. The company is dedicated to the sustainable capture and recovery of waste anaesthetic gases, producing branded generic anaesthetics. The Canadian Venture Capital division of Crédit Mutuel Equity and Round Pound Ventures, LLC were the round's principal investors. The company plans to utilize the money to broaden operations and clientele.
Drivers:
The increasing number of surgeries – The rising incidence of cardiovascular disease, given the lack of physical exercise and unhealthy diet, has contributed to the rising demand for heart surgeries. The increasing hours spent on laptops or the extended screen hours have led to several individuals developing eye disorders. The rising geriatric population also drives the demand for surgeries, including cataracts, heart and ENT. The increasing incidence of cancer is also contributing to the surgical market. The increasing government healthcare expenditure and rising disposable income of the population have made surgeries accessible and affordable. Technological advancements have improved surgical outcomes instilling confidence in patients about these treatment options. The empirical evidence backing the success of these surgical interventions with concrete data helps convince patients to opt for surgeries. Therefore, the growing number of patients opting for surgical interventions will drive the global inhalation anaesthetics market. Appendectomy and C-section surgeries are the topmost contributors to the global inhalation anaesthetics market.
Restraints:
Environmental concerns – Inhalation anaesthetics are halogenated chlorofluorocarbons. They are halothane, isoflurane, sevoflurane and desflurane. As common knowledge has it, they are toxic to the environment. They significantly contribute to the depletion of the ozone layer. The ozone layer is a protective layer in the atmosphere that keeps the sun's harmful UV rays from entering the atmosphere and reaching the earth. Ozone depletion leads to global warming. The warming of the global average temperature is causing catastrophic climate change worldwide. The rising concerns about the climate change crisis have grappled the world in recent times, and several initiatives have been aimed at reducing the greenhouse gases in the atmosphere to arrest temperature rise. The use of inhalation anaesthetics is also being debated as they are potent greenhouse gases which stay in the atmosphere for an extended duration and contribute to climate change. Therefore, the environmental concerns associated with inhalation anaesthetics will hamper the market’s growth.
Opportunities:
Product innovations – The increasing diagnosis of cancer and other chronic diseases globally has also increased the demand for surgeries. The increasing demand for surgeries drives the global inhalation anaesthetics market. Government and international organizations anticipate the demand for surgeries to continue in the future and advancement in medicine. Therefore, government authorities and private market players are investing heavily in developing better inhalation anaesthetics to exploit the expanding surgical market. The produce innovations aim to easily administer inhalation anaesthetics, enhancing their precision and safety. Innovations enable the global world to reduce the magnitude of negative environmental effects caused by inhalation anaesthetics. Such innovations and advancements will offer lucrative opportunities during the forecast period.
Challenges:
Stringent regulatory approvals – Surgical interventions are sought after extensive thought as they are invasive and do not guarantee success. The risks involved in surgeries are higher given the aspects involved in the pre-op, post-op or during the actual procedure. The risks can be managed by reducing the risks associated with negligence by the surgeon or assistant doctors and using tested drugs. Since inhalation anaesthetics directly impact the patient's health and the course of the entire procedure, they need to be approved after proper scrutiny. Even surgical procedures are governed by guidelines and rules set by authorities in the patient's interest. Therefore, the stringent regulatory approvals for anaesthetics and their use in medicine will challenge the market's growth.
Regional segmentation analysis:
The regions analyzed for the market include North America, Europe, South America, Asia Pacific, the Middle East, and Africa. The North American region emerged as the most significant global inhalation anaesthetics market, with a 39.55% market revenue share in 2022. The highly advanced and extensive network of healthcare expenditure ensuring last-mile delivery of healthcare service to every citizen aid the growth of the market. The government's high per capita healthcare expenditure and several positive reimbursements and other initiatives also facilitate the market's growth. The presence of hospitals and positive reimbursement policies ensure accessibility and affordability of surgical procedures if opted for by the patient. Furthermore, significant market players producing inhalation anaesthetics ensure uninterrupted supply to these hospitals. The increasing incidence of cancer will propel the growth of the market. Similarly, the increasing prevalence of cardiovascular, ENT and other acute or chronic diseases will augment the regional inhalation anaesthetics market. The significant geriatric population is also a contributor to the market. The Asia Pacific market is expected to grow the fastest during the forecast period, given its vast and advanced pharmaceutical sector.
North America Inhalation Anesthetics Market Share in 2022 – 39.55%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
Drug segment analysis
The drug segment is divided into sevoflurane, isoflurane, desflurane, halothane, nitrous oxide and others. The sevoflurane segment dominated the market with a revenue share of around 39% in 2022. Sevoflurane is a general anaesthetic used before or during surgery. It has the fastest onset meaning its effects sets in faster than the other anaesthetics explaining its dominance in the market. It does not have an unacceptable cardiovascular profile. It is a sweet-smelling drug with a manageable odour. Sevoflurane assists in faster recovery. Sevoflurane usually works for all patients, including paediatrics. It also has minimal complications and high effectiveness. The multiple benefits offered by sevoflurane over other drugs contribute to its dominance in the market.
Application segment analysis
The application segment is divided into induction and maintenance. The maintenance segment dominated the market with a revenue share of around 56% in 2022. Maintenance of anaesthesia describes using anaesthetics to maintain the state of unawareness or temporary loss of awareness in patients under the knife. The patient must continue to sleep or undergo anaesthesia during the procedure. Inhalation anaesthetics are highly effective in maintenance and are flexible, allowing doctors to adjust the dosage accordingly to maintain the state of unawareness. Since maintenance is the primary function of anaesthetics, it dominates the market.
End-user segment analysis
The end-user segment is divided into hospitals, ambulatory surgical centres and others. The hospital segment dominated the market with a revenue share of around 53% in 2022. Hospitals are institutions that administer all forms of healthcare services. They are the first point of care. Patients reach out to these institutions in case of any healthcare needs. They offer services in multiple domains. They offer services at all levels, from prescribing drugs to surgeries. Increasing healthcare expenditure will contribute to the development and advancement of surgical infrastructure globally, augmenting the segment's growth and the market.
Report Description:
| Attribute | Description |
|---|---|
| Market Size | Revenue (USD Billion) |
| Market size value in 2022 | USD 1.78 Billion |
| Market size value in 2030 | USD 2.76 Billion |
| CAGR (2022 to 2030) | 5.66% |
| Historical data | 2019-2020 |
| Base Year | 2021 |
| Forecast | 2022-2030 |
| Segments | The regions examined for the market are Europe, Asia Pacific, North America, South America, and Middle East & Africa. |
| Regional Segments | The research segment is based on drug, application, and end-user. |
As per The Brainy Insights, the size of the inhalation anesthetics market was valued at USD 1.78 billion in 2022 to USD 2.76 billion by 2030.
The global inhalation anesthetics market is growing at a CAGR of 5.66% during the forecast period 2022-2030.
The North American region emerged as the largest market for the inhalation anesthetics.
The increasing incidence of chronic and acute diseases will influence the market's growth.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis by Drug
4.3.2. Market Attractiveness Analysis by Application
4.3.3. Market Attractiveness Analysis by End User
4.3.4. Market Attractiveness Analysis by Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. The increasing incidence of chronic and acute diseases
5.3. Restraints
5.3.1. Inhalation anaesthetics are potent greenhouse gases
5.4. Opportunities
5.4.1. Increasing expenditure to develop better products
5.5. Challenges
5.5.1. Surgical procedures are governed by stringent guidelines and regulations
6. Global Inhalation Anesthetics Market Analysis and Forecast, By Drug
6.1. Segment Overview
6.2. Sevoflurane
6.3. Isoflurane
6.4. Desflurane
6.5. Halothane
6.6. Nitrous Oxide
6.7. Others
7. Global Inhalation Anesthetics Market Analysis and Forecast, By Application
7.1. Segment Overview
7.2. Induction
7.3. Maintenance
8. Global Inhalation Anesthetics Market Analysis and Forecast, By End User
8.1. Segment Overview
8.2. Hospitals
8.3. Ambulatory Surgical Centers
8.4. Others
9. Global Inhalation Anesthetics Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global Inhalation Anesthetics Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in the Inhalation Anesthetics Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. AbbVie Inc.
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. Abbott Laboratories
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. Baxter International Inc.
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. Fresenius SE & Co.
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Halocarbon Products Corporation
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. Hikma Pharmaceuticals PLC
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. Jiangsu Hengrui Medicine Co. Ltd.
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. Lunan Pharmaceutical Group Co. Ltd.
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Piramal Enterprises Ltd.
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. Sandoz International GmbH (Novartis)
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company Product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
List of Table
1. Global Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
2. Global Sevoflurane Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
3. Global Isoflurane Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
4. Global Desflurane Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
5. Global Halothane Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
6. Global Nitrous Oxide Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
7. Global Others Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
8. Global Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
9. Global Induction Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
10. Global Maintenance Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
11. Global Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
12. Global Hospitals Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
13. Global Ambulatory Surgical Centers Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
14. Global Others Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
15. Global Inhalation Anesthetics Market, By Region, 2019-2030 (USD Billion)
16. North America Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
17. North America Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
18. North America Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
19. U.S. Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
20. U.S. Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
21. U.S. Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
22. Canada Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
23. Canada Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
24. Canada Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
25. Mexico Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
26. Mexico Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
27. Mexico Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
28. Europe Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
29. Europe Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
30. Europe Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
31. Germany Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
32. Germany Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
33. Germany Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
34. France Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
35. France Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
36. France Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
37. U.K. Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
38. U.K. Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
39. U.K. Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
40. Italy Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
41. Italy Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
42. Italy Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
43. Spain Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
44. Spain Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
45. Spain Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
46. Asia Pacific Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
47. Asia Pacific Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
48. Asia Pacific Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
49. Japan Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
50. Japan Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
51. Japan Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
52. China Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
53. China Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
54. China Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
55. India Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
56. India Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
57. India Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
58. South America Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
59. South America Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
60. South America Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
61. Brazil Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
62. Brazil Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
63. Brazil Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
64. Middle East and Africa Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
65. Middle East and Africa Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
66. Middle East and Africa Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
67. UAE Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
68. UAE Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
69. UAE Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
70. South Africa Inhalation Anesthetics Market, By Drug, 2019-2030 (USD Billion)
71. South Africa Inhalation Anesthetics Market, By Application, 2019-2030 (USD Billion)
72. South Africa Inhalation Anesthetics Market, By End User, 2019-2030 (USD Billion)
List of Figures
1. Global Inhalation Anesthetics Market Segmentation
2. Inhalation Anesthetics Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top-Down Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Inhalation Anesthetics Market Attractiveness Analysis by Drug
9. Global Inhalation Anesthetics Market Attractiveness Analysis by Application
10. Global Inhalation Anesthetics Market Attractiveness Analysis by End User
11. Global Inhalation Anesthetics Market Attractiveness Analysis by Region
12. Global Inhalation Anesthetics Market: Dynamics
13. Global Inhalation Anesthetics Market Share by Drug (2022 & 2030)
14. Global Inhalation Anesthetics Market Share by Application (2022 & 2030)
15. Global Inhalation Anesthetics Market Share by End User (2022 & 2030)
16. Global Inhalation Anesthetics Market Share by Regions (2022 & 2030)
17. Global Inhalation Anesthetics Market Share by Company (2021)
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the global inhalation anesthetics market based on below-mentioned segments:
Global Inhalation Anesthetics Market by Drug:
Global Inhalation Anesthetics Market by Application:
Global Inhalation Anesthetics Market by End User:
Global Inhalation Anesthetics Market by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date
